Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma

References

• Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994; 21: 403–10
   PubMed Web of Science ®Google Scholar
• Van Rensburg SJ. Epidemiologic and dietary evidence for a specific nutritional predisposition to esophageal cancer. J Natl Cancer Inst 1981; 67: 243–51
   PubMed Web of Science ®Google Scholar
• Gustavsson P, Evanoff B, Hogstedt C. Increased risk of esophageal cancer among workers exposed to combustion products. Arch Environ Health 1993; 48: 243–5
   PubMed Web of Science ®Google Scholar
• Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005; 26: 1748–53
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang X, Huang G, Miao X, Guo L, Lin D, Lu SH. Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis 2006; 27: 798–802
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G, et al. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003; 105: 281–4
   PubMed Web of Science ®Google Scholar
• Liebau C, Baltzer AW, Schmidt S, Roesel C, Karreman C, Prisack JB, et al. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res 2002; 22: 931–6
   PubMed Web of Science ®Google Scholar
• Moore MB, Kurago ZB, Fullenkamp CA, Lutz CT. Squamous cell carcinoma cells differentially stimulate NK cell effector functions: The role of IL-18. Cancer Immunol Immunother 2003; 52: 107–15
   PubMedGoogle Scholar
• Chia CS, Ban K, Ithnin H, Singh H, Krishnan R, Mokhtar S, et al. Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma. Immunol Lett 2002; 84: 163–72
   PubMedGoogle Scholar
• Tsuboi K, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Manda R, et al. Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma. Cancer Lett 2004; 205: 207–14
   PubMedGoogle Scholar
• Xia D, Li F, Xiang J. Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity. Cancer Biother Radiopharm 2004; 19: 322–30
   PubMedGoogle Scholar
• Han MY, Zheng S, Yu JM, Peng JP, Guo QS, Wang JL. Study on interleukin-18 gene transfer into human breast cancer cells to prevent tumorigenicity. J Zhejiang Univ Sci 2004; 5: 472–6
   PubMedGoogle Scholar
• Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–52
   PubMed Web of Science ®Google Scholar
• Imboden M, Nicod L, Nieters A, Glaus E, Matyas G, Bircher AJ, et al. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study. Clin Exp Allergy 2006; 36: 211–8
   PubMed Web of Science ®Google Scholar
• Jang WC, Park SB, Nam YH, Lee SS, Kim JW, Chang IS, et al. Interleukin-18 gene polymorphisms in Korean patients with Behcet's disease. Clin Exp Rheumatol 2005; 23: S59–S63
   Google Scholar
• Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005; 112: 643–50
   PubMed Web of Science ®Google Scholar
• Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005; 6: 211–6
   PubMed Web of Science ®Google Scholar
• Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R, et al. Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother 2006; 55: 23–30
   PubMedGoogle Scholar
• Bushley AW, Ferrell R, McDuffie K, Terada KY, Carney ME, Thompson PJ, et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004; 95: 672–9
   PubMed Web of Science ®Google Scholar
• Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, Fukushima T, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004; 22: 73–8
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97–8
   PubMed Web of Science ®Google Scholar
• Stephens M, Smith MJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–89
   PubMed Web of Science ®Google Scholar
• Sivalingam SP, Yoon KH, Koh DR, Fong KY. Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: Protective effect of AA genotype. Tissue Antigens 2003; 62: 498–504
   PubMedGoogle Scholar
• Novota P, Kolostova K, Pinterova D, Novak J, Treslova L, Andel M, et al. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 2005; 96: 247–51
   PubMed Web of Science ®Google Scholar
• Rueda B, Gonzalez-Gay MA, Mataran L, Lopez-Nevot MA, Martin J. Interleukin-18 promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens. 2005; 65: 544–8
   PubMedGoogle Scholar
• Cardoso SM, DeFor TE, Tilley LA, Bidwell JL, Weisdorf DJ, MacMillan ML. Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation. Br J Haematol 2004; 126: 704–10
   PubMed Web of Science ®Google Scholar
• Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005; 6: 211–6
   PubMed Web of Science ®Google Scholar
• Charles AD. Interleukin-18. Methods 1999; 19: 121–32
   PubMedGoogle Scholar
• Nouh MA, Eissa SA, Zaki SA, El-Maghraby SM, Kadry DY. Importance of Serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst 2005; 17: 51–5
   PubMedGoogle Scholar
• Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006; 12: 4473–7
   PubMed Web of Science ®Google Scholar
• Takagawa T, Tamura K, Takeda N, Tomita T, Ohda Y, Fukunaga K, et al. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005; 11: 1038–43
   PubMed Web of Science ®Google Scholar